全文获取类型
收费全文 | 11607篇 |
免费 | 900篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 615篇 |
妇产科学 | 305篇 |
基础医学 | 1746篇 |
口腔科学 | 240篇 |
临床医学 | 1061篇 |
内科学 | 2568篇 |
皮肤病学 | 130篇 |
神经病学 | 997篇 |
特种医学 | 488篇 |
外科学 | 1984篇 |
综合类 | 230篇 |
一般理论 | 3篇 |
预防医学 | 778篇 |
眼科学 | 221篇 |
药学 | 509篇 |
中国医学 | 11篇 |
肿瘤学 | 563篇 |
出版年
2021年 | 109篇 |
2019年 | 107篇 |
2018年 | 138篇 |
2017年 | 118篇 |
2016年 | 118篇 |
2015年 | 138篇 |
2014年 | 229篇 |
2013年 | 318篇 |
2012年 | 410篇 |
2011年 | 427篇 |
2010年 | 247篇 |
2009年 | 230篇 |
2008年 | 438篇 |
2007年 | 412篇 |
2006年 | 396篇 |
2005年 | 471篇 |
2004年 | 431篇 |
2003年 | 373篇 |
2002年 | 389篇 |
2001年 | 375篇 |
2000年 | 360篇 |
1999年 | 312篇 |
1998年 | 155篇 |
1997年 | 137篇 |
1996年 | 132篇 |
1995年 | 124篇 |
1992年 | 289篇 |
1991年 | 280篇 |
1990年 | 291篇 |
1989年 | 313篇 |
1988年 | 292篇 |
1987年 | 295篇 |
1986年 | 278篇 |
1985年 | 257篇 |
1984年 | 182篇 |
1983年 | 202篇 |
1982年 | 130篇 |
1981年 | 135篇 |
1980年 | 125篇 |
1979年 | 222篇 |
1978年 | 198篇 |
1977年 | 152篇 |
1976年 | 164篇 |
1975年 | 149篇 |
1974年 | 144篇 |
1973年 | 146篇 |
1972年 | 150篇 |
1971年 | 108篇 |
1970年 | 103篇 |
1969年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Periodic limb movements in sleep in community-dwelling elderly. 总被引:6,自引:0,他引:6
The prevalence of periodic limb movements in sleep (PLMS) in a randomly selected elderly sample is reported. In San Diego, 427 elderly volunteers aged 65 yr and over were recorded in their homes. Forty-five percent had a myoclonus index, MI greater than or equal to 5. Correlates of PLMS included dissatisfaction with sleep, sleeping alone and reported kicking at night. Although statistically significant, the strengths of the associations between interview variables and myoclonus indices were all small. No combination of demographic variables and symptoms allowed highly reliable prediction of PLMS. 相似文献
142.
Overproduction and purification of the luxR gene product: Transcriptional activator of the Vibrio fischeri luminescence system 下载免费PDF全文
Kaplan HB Greenberg EP 《Proceedings of the National Academy of Sciences of the United States of America》1987,84(19):6639-6643
Expression of Vibrio fischeri luminescence genes requires an inducer, termed autoinducer, and a positive regulatory element, the luxR gene product. A plasmid containing luxR under control of a tac promoter was engineered to overproduce this gene product. The overproduced luxR gene product was active in vivo, and its apparent monomeric molecular weight was indistinguishable from that of the protein encoded by luxR under control of its own promoter (M(r) 27,000). The new tac-luxR construct directed the synthesis of large quantities of the luxR gene product in induced Escherichia coli cells lacking other lux genes. In the presence of the other lux genes, overexpression of the tac-luxR construct was not detected. The overproduced luxR gene product, which formed cytoplasmic inclusion bodies, was purified and used in subsequent studies. Nonequilibrium pH gradient electrophoresis indicated that the protein was basic, and the amino-terminal 15 amino acids were sequenced. DNA-binding activity was detected by membrane filter binding assays; under the conditions used, the binding was not lux DNA-specific. Binding of tritium-labeled autoinducer to the luxR gene product was not detected, and autoinducer enhancement of the binding of the luxR gene product to DNA could not be detected reproducibly. 相似文献
143.
144.
Rao VM; Dalinka MK; Mitchell DG; Spritzer CE; Kaplan F; August CS; Axel L; Kressel HY 《Radiology》1986,161(1):217-220
Four patients with proved osteopetrosis (three with the infantile malignant form and one with the benign form) were examined with magnetic resonance imaging at 1.5 T. All patients were studied in the coronal and sagittal planes using both short and long repetition time/echo time sequences. The infantile malignant form was characterized by a complete lack of signal from the marrow alternating with a signal intensity equivalent to that of the intervertebral disks, resulting in a "stepladder" appearance. In the benign form or after successful marrow transplantation in the infantile malignant form, intermediate or high signal intensity in the vertebrae was noted, suggesting the presence of some marrow elements. 相似文献
145.
N. Simon Tchekmedyian Merrill J. Egorin Brian E. Cohen Richard S. Kaplan Elizabeth Poplin Joseph Aisner 《Cancer chemotherapy and pharmacology》1986,18(1):33-38
Summary A total of 14 patients, 7 male and 7 female, received in all 21 evaluable courses of cyclophosphamide administered by 5-day continuous infusion. Cyclophosphamide doses were escalated from 300 to 400 mg/m2 per day for 5 days and repeated every 21–28 days. The patient population had a median age of 55 years (range 38–76) and a median Karnofsky performance status of 80 (range 60–100). Only 1 patient had not received prior therapy; 5 patients had received only prior chemotherapy, 1 had received only prior radiotherapy, and 7 had received both. Tumor types were gastric (1), lung (2), colon (4), urethral adenocarcinoma (1), cervical (2), chondrosarcoma (1), melanoma (1), uterine leiomyosarcoma (1), and pancreatic (1). The dose-limiting toxicity was granulocytopenia, with median WBC nadir of 1700/l (range 100–4800) in 8 heavily pretreated patients treated at 350 mg/m2 per day for 5 days. One patient without heavy prior treatment received two courses at 400 mg/m2 and had WBC nadirs of 800/l and 600l. WBC nadirs occurred between days 9 and 21 (median 14). Drug-induced thrombocytopenia occurred in only one patient (350 mg/m2 per day, nadir 85000/l). Neither hyponatremia nor symptomatic hypoosmolality was observed. Radiation-induced hemorrhagic cystitis may have been worsened in one patient. Nausea and vomiting were mild. Objective remissions were not observed. The maximum tolerated dose for previously treated patients is 350 mg/m2 per day for 5 days. This dose approximates the doses of cyclophosphamide commonly used with bolus administration. Plasma steady-state concentrations (Css) of cyclophosphamide, measured by gas liquid chromatography, were 2.09–6.79 g/ml. Steady state was achieved in 14.5±5.9 h (mean ±SD). After the infusion, cyclophosphamide disappeared from plasma monoexponentially, with a t1/2 of 5.3±3.6 h. The area under the curve of plasma cyclophosphamide concentrations versus time (AUC) was 543±150 g/ml h and reflected a cyclophosphamide total-body clearance (CLTB) of 103±31.6 ml/min. Plasma alkylating activity, assessed by p-nitrobenzyl-pyridine, remained steady at 1.6–4.3 g/ml nor-nitrogen mustard equivalents. Urinary excretion of cyclophosphamide and alkylating activity accounted for 9.3%±7.6% and 15.1%±2.0% of the administered daily dose, respectively. The t1/2 and AUC of cyclophosphamide associated with the 5-day continuous infusion schedule are similar to those reported after administration of cyclophosphamide 1500 mg/m2 as an i.v. bolus. The AUC of alkylating activity associated with the 5-day continuous infusion of cyclophosphamide is about three times greater than the AUC of alkylating activity calculated after a 1500-mg/m2 bolus dose of cyclophosphamide. Daily urinary excretions of cyclophosphamide and alkylating activity associated with the 5-day continuous infusion schedule are similar to those reported after bolus doses of cyclophosphamide. 相似文献
146.
Tanaz Vaghaiwalla Brian Ruhle Kelvin Memeh Peter Angelos Edwin Kaplan Chih-Yi Liao Blase Polite Xavier Keutgen 《Surgery》2021,169(1):162-167
BackgroundPeptide receptor radionuclide therapy is a targeted therapy used to treat unresectable somatostatin receptor-positive neuroendocrine tumors. The objective of this study was to evaluate response rates among neuroendocrine tumors of different primaries and identify factors relevant to future treatment strategies.MethodsWe retrospectively reviewed patients who received peptide receptor radionuclide therapy for neuroendocrine tumors from 2018 to 2019 at our institution. Patients were assessed with computed tomography/magnetic resonance imaging and 68Ga-DOTATATE-positron emission tomography before and after 2 or 4 cycles of peptide receptor radionuclide therapy. Tumor response was evaluated by RECIST 1.1. Statistics included multinomial logistic regression models and Fisher exact test.ResultsTwenty-seven patients underwent 92 cycles of peptide receptor radionuclide therapy: pancreas (n = 11), small bowel (n = 7), and other (n = 9) neuroendocrine tumors. Overall, 30% (8 of 27) had partial response, 59% (16 of 27) stable disease, and 11% (3 of 27) progressed. Pancreatic neuroendocrine tumors responded differently from small bowel neuroendocrine tumors regardless of cycle number (P = .01). The majority of pancreatic neuroendocrine tumors (6 of 11) had partial response to peptide receptor radionuclide therapy, while all small bowel neuroendocrine tumors had stable disease. Pancreatic neuroendocrine tumors stable after 2 cycles were more likely to respond to additional cycles versus other neuroendocrine tumors (probability: 60% vs 11%).ConclusionPatients with unresectable advanced or metastatic pancreatic neuroendocrine tumors may benefit from a full course of peptide receptor radionuclide therapy, whereas other neuroendocrine tumors appear less likely to respond. Large prospective studies are needed to confirm these findings. 相似文献
147.
Differences in the mother-infant relations of squirrel monkeys housed in social and restricted environments 总被引:1,自引:0,他引:1
J Kaplan 《Developmental psychobiology》1972,5(1):43-52
Mother and infant squirrel monkeys were housed together in either a group or a restricted environment until the infants were approximately 22 weeks of age. Observations of the mothers' and infants' behavior during this period revealed clear differences between the rearing conditions. Mothers in the socially restricted environment avoided and punished their infants more and were generally less protective than those in the group environment. However, these differences did not appear to reflect differences in maternal attitudes per se, but rather the extent to which infants in the two environments engaged in certain activities. Infants in the restricted environment attempted to play with their mother more often and remained closer to her as they became older. 相似文献
148.
Kaplan RS 《Journal of clinical engineering》1990,15(3):219-225
A materials management system capable of inventory control, accounting and the automatic recording of supplies for a clinical department has been developed for the George Washington University Hospital Department of Anesthesia. This system combines a microprocessor-based computer for data storage and a hand-held bar code reader to record the bar code scan of each item in the inventory. A relational software program with easy-to-use menus and help keys was written. Bar code information stored for each item includes item number, quantity, date and time of issue. Accumulated bar code scans are loaded into the computer by use of a serial port and then used to update current inventory in the computer. Comparison between current inventory and reorder levels by the computer will initiate automatic printing of appropriate purchase orders. Reorder levels are adjusted regularly, by comparing previous year or month usage to current needs; items already on order, items on back order and delivery lag time are also taken into account. 相似文献
149.
It would appear from the above that Pritchard agrees with the use of some agents other than magnesium sulfate that have known anticonvulsant properties. We believe that the subject at issue is whether magnesium sulfate should be used in treating the seizures of eclampsia. In our "Controversies" article, we do not address the issue of whether magnesium sulfate modifies pathophysiological factors leading to preeclampsia, but restrict ourselves to the treatment of the seizure per se, once seizures supervene, and the avoidance of their recurrence. The pathophysiological mechanisms and optimal treatment of preeclampsia and of eclampsia (excepting seizures) remain to be determined, as does the use of magnesium sulfate in this condition. Eclamptic seizures are clinically and electroencephalographically indistinguishable from generalized tonic-clonic seizures. Whether seizures arise in or out of the setting of preeclampsia, they should be treated as are other seizures, with known anticonvulsants. Controlled clinical trials are needed to address the effectiveness of alternative antiseizure regimens. 相似文献
150.
Bernard S. Kaplan Thomas G. Cleary Thomas G. Obrig 《Pediatric nephrology (Berlin, Germany)》1990,4(3):276-283
One of the requirements for an agent to cause hemolytic uremic syndrome (HUS) is its ability to injure endothelial cells. Shiga-like toxin (SLT) can do this. SLT is produced byEscherichia coli andShigella dysenteriae serotype 1; both have been implicated as causes of typical HUS. Endothelial cells have receptors (GB3) for SLT and the toxin can inhibit eukaryotic protein synthesis, thereby causing cell death. Glomerular endothelial cell injury or death results in a decreased glomerular filtration rate and many of the perturbations seen in HUS. It is no longer certain that hemolysis is the result of a microangiopathy. Cell injury results in release of von Willebrand multimers; if these are ultra-large, thrombosis may ensue. There is also increasing evidence that neutrophils have a role in the pathogenesis of typical HUS.Streptococcus pneumoniae can also cause HUS and care must be taken to avoid giving plasma to patients withS. pneumoniae-associated HUS. There is compelling evidence that types of HUS are inherited by autosomal recessive and autosomal dominant modes. Patients with autosomal recessive HUS may have recurrent episodes. Mortality and morbidity rates are high for the inherited forms. 相似文献